← FDA DRUG APPROVALS

FDA ANDA · ANDA075402

METAPROTERENOL SULFATE

Sponsor: APOTEX INC

APPLICATION
ANDA075402
TYPE
ANDA
ORIGINAL APPROVAL
2001-02-28
LATEST ACTION
2001-02-28
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

METAPROTERENOL SULFATEDiscontinued
METAPROTERENOL SULFATE 0.4% · SOLUTION · INHALATION

Approval history

2001-02-28OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →